A groundbreaking leap for personalized medicine! This week, a leading oncology center in Germany became the first hospital in Europe to integrate real-time tumor genomic sequencing into everyday cancer care. Now, oncologists can receive a patient’s comprehensive tumor DNA profile within 48 hours, enabling tailored treatment plans from the very start. This advancement promises more accurate therapies, reduced trial-and-error, and a new benchmark in patient outcomes. How will rapid genomics change your clinical workflow? Join the conversation and share your thoughts on the future of precision oncology! 🌍🧬